Benchmark Holdings plc
General ticker "BHCCF" information:
- Sector: Health Care
- Industry: Drug Manufacturers - Specialty & Generic
- Capitalization: $293.7M (TTM average)
Benchmark Holdings plc does not follow the US Stock Market performance with the rate: -14.1%.
Estimated limits based on current volatility of 0.0%: low 0.37$, high 0.37$
Short-term BHCCF quotes
Long-term BHCCF plot
Financial data
| YTD | 2022-09-30 | 2023-09-30 | 2024-09-30 |
|---|---|---|---|
| Operating Revenue | £158.28MM | £169.48MM | £90.36MM |
| Operating Expenses | £164.51MM | £174.79MM | £125.86MM |
| Operating Income | £-6.23MM | £-5.32MM | £-35.50MM |
| Non-Operating Income | £-15.15MM | £-7.38MM | £-10.43MM |
| Interest Expense | £11.25MM | £10.50MM | £8.04MM |
| R&D Expense | £8.80MM | £6.07MM | £2.44MM |
| Income(Loss) | £-21.38MM | £-12.69MM | £-45.92MM |
| Taxes | £7.27MM | £3.37MM | £-1.65MM |
| Profit(Loss)* | £-32.09MM | £-23.15MM | £-39.46MM |
| Stockholders Equity | £313.40MM | £276.40MM | £218.26MM |
| Inventory | £55.59MM | £52.85MM | £23.67MM |
| Assets | £526.57MM | £471.30MM | £384.90MM |
| Operating Cash Flow | £10.81MM | £20.00MM | £2.00MM |
| Capital expenditure | £12.72MM | £6.78MM | £3.93MM |
| Investing Cash Flow | £-11.22MM | £-5.27MM | £-2.83MM |
| Financing Cash Flow | £-6.92MM | £-12.33MM | £-10.97MM |
| Earnings Per Share** | £-0.05 | £-0.02 | £-0.05 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.